Based upon the know profile biding affinity and normal profiling of comparable compounds, it would be safe to presume that AMB-FUBINACA can work as a strong agonist at the CB1 receptor subgroup. There's one bit of exploration which does confirm the above mentioned declare of affinity with the CB1 receptor https://waylonmlfzq.tblogz.com/what-does-amb-series-mean-32549707